Sort   by:  
 Page size 
UnknownPhase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia.
Not available
S-EPMC5477824 | biostudies-literature
UnknownPhase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia.
Not available
S-EPMC3158600 | biostudies-literature
UnknownOutcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.
Not available
S-EPMC4162497 | biostudies-literature
UnknownInherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.
Not available
S-EPMC4375304 | biostudies-literature
UnknownMethotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
Not available
S-EPMC3948096 | biostudies-literature
UnknownUtility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids.
Not available
S-EPMC4322260 | biostudies-literature
UnknownComparative analysis of different approaches to measure treatment response in acute myeloid leukemia.
Not available
S-EPMC3462046 | biostudies-literature
UnknownInfluence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy.
Not available
S-EPMC4871998 | biostudies-literature
UnknownClinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.
Not available
S-EPMC4962704 | biostudies-literature
UnknownSecond malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.
Not available
S-EPMC3807139 | biostudies-literature
Sort   by:  
 Page size